Clinical and research tests for C4048306 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 31

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Multiple Endoctine Neoplasia Type 2 (RET) Molecular Genetics Laboratory London Health Sciences Centre Canada	5	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States	97	77	C Sequence analysis of the entire coding region
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States	71	54	C Sequence analysis of the entire coding region
RET Full Gene Analysis Mayo Clinic Laboratories Mayo Clinic United States	2	1	C Sequence analysis of the entire coding region
myRisk Hereditary Cancer Myriad Genetics, Inc. United States	32	46	D Deletion/duplication analysis C Sequence analysis of the entire coding region
VistaSeq RET Comprehensive Molecular Diagnostic Laboratory LabCorp United States	1	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region
ENDOCRINE NEOPLASIA PANEL IntelligeneCG LLC United States	7	7	C Sequence analysis of the entire coding region
Multiple Endocrine Neoplasia, Type 2 panel National Taiwan University Hospital A1 Center National Taiwan University Hospital Taiwan	4	1	C Sequence analysis of the entire coding region
Hereditary Pheochromocytoma and Paraganglioma Panel Genetic Services Laboratory University of Chicago United States	10	16	D Deletion/duplication analysis C Sequence analysis of the entire coding region
VistaSeq Comprehensive Cancer Panel Molecular Diagnostic Laboratory LabCorp United States	47	59	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Hereditary Endocrine Cancer Panel (12 Genes) Quest Diagnostics Nichols Institute San Juan Capistrano United States	6	12	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Comprehensive Hereditary Cancer Panel (66 Genes) Quest Diagnostics Nichols Institute San Juan Capistrano United States	35	66	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Multiple Endocrine Neoplasia Type 2: RET Gene Sequencing CEN4GEN Institute for Genomics and Molecular Diagnostics Canada	1	1	C Sequence analysis of the entire coding region
Endocrine tumours Institute of Human Genetics Cologne University Germany	17	11	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Thyroid Cancer Asper Biogene Asper Biogene LLC Estonia	10	10	C Sequence analysis of the entire coding region
Hereditary Thyroid Cancer Panel Genetic Services Laboratory University of Chicago United States	11	13	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Pediatric Solid Tumors Panel Invitae United States	90	48	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Comprehensive Hereditary Cancer Panel Genetic Services Laboratory University of Chicago United States	25	139	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Thyroid Cancer Panel Invitae United States	23	7	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Hyperparathyroidism Panel Invitae United States	9	5	D Deletion/duplication analysis C Sequence analysis of the entire coding region

<< First< Prev

Page 1 of 2

Results: 1 to 20 of 31

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.